Related references
Note: Only part of the references are listed.Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes
Jie Li et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Key steps in vaccine development
Peter L. Stern
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2020)
Peptide-Based Vaccines: Current Progress and Future Challenges
Ryan J. Malonis et al.
CHEMICAL REVIEWS (2020)
Mucosal vaccines: Strategies and challenges
Miao Li et al.
IMMUNOLOGY LETTERS (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
Syed Faraz Ahmed et al.
VIRUSES-BASEL (2020)
Deaths in healthcare workers due to COVID-19: the need for robust data and analysis
E. Kursumovic et al.
ANAESTHESIA (2020)
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19
Huilan Zhang et al.
ANNALS OF INTERNAL MEDICINE (2020)
Convalescent plasma in Covid-19: Possible mechanisms of action
Manuel Rojas et al.
AUTOIMMUNITY REVIEWS (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
A Mouse Model of SARS-CoV-2 Infection and Pathogenesis
Shi-Hui Sun et al.
CELL HOST & MICROBE (2020)
Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19
Hin Chu et al.
CLINICAL INFECTIOUS DISEASES (2020)
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
Ning Wang et al.
FRONTIERS IN MICROBIOLOGY (2020)
Is BCG vaccination causally related to reduced COVID-19 mortality?
Masayuki Miyasaka
EMBO MOLECULAR MEDICINE (2020)
Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?
Leticia Moreno-Fierros et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Immunology of COVID-19: Current State of the Science
Nicolas Vabret et al.
IMMUNITY (2020)
SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults
Uri Hamiel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
The many faces of the anti-COVID immune response
Santosha A. Vardhana et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2
Kazuma Kiyotani et al.
JOURNAL OF HUMAN GENETICS (2020)
Rapid COVID-19 vaccine development
Barney S. Graham
SCIENCE (2020)
Potential of live pathogen vaccines for defeating the COVID-19 pandemic: History and mechanism
Ji-Wang Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
COVID-19: are neutralizing antibodies neutralizing enough?
Kamran Kadkhoda
TRANSFUSION (2020)
Extraordinary diseases require extraordinary solutions
Stanley A. Plotkin et al.
VACCINE (2020)
Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins
Suhas Srinivasan et al.
VIRUSES-BASEL (2020)
Immunogenicity of a DNA vaccine candidate for COVID-19
Trevor R. F. Smith et al.
NATURE COMMUNICATIONS (2020)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu et al.
LANCET (2020)
Considering BCG vaccination to reduce the impact of COVID-19
Nigel Curtis et al.
LANCET (2020)
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open -label, phase 1 trial
Till Koch et al.
LANCET INFECTIOUS DISEASES (2020)
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
Pedro M. Folegatti et al.
LANCET INFECTIOUS DISEASES (2020)
COVID-19 human challenge studies: ethical issues
Euzebiusz Jamrozik et al.
LANCET INFECTIOUS DISEASES (2020)
An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Fuzhou Wang et al.
MEDICAL SCIENCE MONITOR (2020)
Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
Eun Kim et al.
EBIOMEDICINE (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Questions remain following first COVID-19 vaccine results
Cormac Sheridan
NATURE BIOTECHNOLOGY (2020)
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
Wen Wen et al.
CELL DISCOVERY (2020)
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series
Pavan K. Bhatraju et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
Hui Wang et al.
CELL (2020)
Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS
Walter Fierz et al.
FRONTIERS IN IMMUNOLOGY (2020)
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials
Shengli Xia et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The laboratory tests and host immunity of COVID-19 patients with different severity of illness
Feng Wang et al.
JCI INSIGHT (2020)
Coronavirus Pandemic-Therapy and Vaccines
Kenneth Lundstrom
BIOMEDICINES (2020)
Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains
Eriko Padron-Regalado
INFECTIOUS DISEASES AND THERAPY (2020)
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
Giovanni Salvatori et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2
Parismita Kalita et al.
MICROBIAL PATHOGENESIS (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
COVID-19 vaccine development and a potential nanomaterial path forward
Matthew D. Shin et al.
NATURE NANOTECHNOLOGY (2020)
Amplifying RNA Vaccine Development
Deborah H. Fuller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Two Randomized Controlled Trials of Bacillus Calmette-Guerin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials
Thijs ten Doesschate et al.
TRIALS (2020)
Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers
Umit H. Kartoglu et al.
VACCINE (2020)
Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2
Yi Zhang et al.
NATURE COMMUNICATIONS (2020)
Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
Tania Gupta et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
What about the original antigenic sin of the humans versus SARS-CoV-2?
Luca Roncati et al.
MEDICAL HYPOTHESES (2020)
Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae
Zhiqian Ma et al.
IMMUNOPATHOLOGY (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019
Jianbo Lai et al.
JAMA NETWORK OPEN (2020)
A Controlled Human Infection Model of Group A Streptococcus Pharyngitis: Which Strain and Why?
Joshua Osowicki et al.
MSPHERE (2019)
Non-specific effects of BCG vaccine on viral infections
S. J. C. F. M. Moorlag et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
Kayvon Modjarrad et al.
LANCET INFECTIOUS DISEASES (2019)
Original Antigenic Sin and Respiratory Syncytial Virus Vaccines
Ralph A. Tripp et al.
VACCINES (2019)
CEPI: Driving Progress Towards Epidemic Preparedness And Response
Dimitrios Gouglas et al.
EPIDEMIOLOGIC REVIEWS (2019)
Original Antigenic Sin: How First Exposure Shapes Lifelong Anti-Influenza Virus Immune Responses
Ali Zhang et al.
JOURNAL OF IMMUNOLOGY (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
Yushun Wan et al.
JOURNAL OF VIROLOGY (2019)
Rapid Protective Effects of Early BCG on Neonatal Mortality Among Low Birth Weight Boys: Observations From Randomized Trials
Sofie Biering-Sorensen et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Effect of sex on vaccination outcomes: important but frequently overlooked
Alice Harper et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis
Jason K. H. Lee et al.
EXPERT REVIEW OF VACCINES (2018)
Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape
Lingshu Wang et al.
JOURNAL OF VIROLOGY (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Giuseppe Del Giudice et al.
SEMINARS IN IMMUNOLOGY (2018)
Recent Advances in Vaccine Technologies
Michael James Francis
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2018)
Opinion: Making Inactivated and Subunit-Based Vaccines Work
Brendon Y. Chua et al.
VIRAL IMMUNOLOGY (2018)
DNA VaccinesHow Far From Clinical Use?
Dominika Hobernik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Nanoparticle Vaccines Against Infectious Diseases
Rashmirekha Pati et al.
FRONTIERS IN IMMUNOLOGY (2018)
National Immunization Campaigns with Oral Pao Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials
Andreas Andersen et al.
FRONTIERS IN PUBLIC HEALTH (2018)
Herpes zoster and the search for an effective vaccine
N. Arnold et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Sex-differential heterologous (non-specific) effects of vaccines: an emerging public health issue that needs to be understood and exploited
Katie L. Flanagan et al.
EXPERT REVIEW OF VACCINES (2017)
Original antigenic sin: A comprehensive review
Anup Vatti et al.
JOURNAL OF AUTOIMMUNITY (2017)
Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies
Marc Rondy et al.
JOURNAL OF INFECTION (2017)
CEPI-a new global R&D organisation for epidemic preparedness and response
Borge Brende et al.
LANCET (2017)
Typhoid vaccine development with a human challenge model
Nicholas A. Feasey et al.
LANCET (2017)
Major findings and recent advances in virus like particle (VLP)-based vaccines
Mona O. Mohsen et al.
SEMINARS IN IMMUNOLOGY (2017)
Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis
Alexander Domnich et al.
VACCINE (2017)
Vaccines for epidemic infections and the role of CEPI
Stanley A. Plotkin
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Vaccine adjuvants: smart components to boost the immune system
Rakesh Bastola et al.
ARCHIVES OF PHARMACAL RESEARCH (2017)
Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses
Jingxian Zhao et al.
SCIENCE IMMUNOLOGY (2017)
Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
Anurodh Shankar Agrawal et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Original Antigenic Sin Response to RNA Viruses and Antiviral Immunity
Mee Sook Park et al.
IMMUNE NETWORK (2016)
Sex differences in immune responses
Sabra L. Klein et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Evaluation of candidate vaccine approaches for MERS-CoV
Lingshu Wang et al.
NATURE COMMUNICATIONS (2015)
Genetic drift of human coronavirus OC43 spike gene during adaptive evolution
Lili Ren et al.
SCIENTIFIC REPORTS (2015)
BCG-induced trained immunity in NK cells: Role for non-specific protection to infection
Johanneke Kleinnijenhuis et al.
CLINICAL IMMUNOLOGY (2014)
T cell-mediated immune response to respiratory coronaviruses
Rudragouda Channappanavar et al.
IMMUNOLOGIC RESEARCH (2014)
Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
Johanneke Kleinnijenhuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Regulatory T Cells in Arterivirus and Coronavirus Infections: Do They Protect Against Disease or Enhance it?
Thomas E. Cecere et al.
VIRUSES-BASEL (2012)
Vaccination in the elderly
Evelyna Derhovanessian et al.
MICROBIAL BIOTECHNOLOGY (2012)
Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study
Fang Tang et al.
JOURNAL OF IMMUNOLOGY (2011)
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response
Meagan Bolles et al.
JOURNAL OF VIROLOGY (2011)
Retinoic Acid as a Vaccine Adjuvant Enhances CD8+ T Cell Response and Mucosal Protection from Viral Challenge
Xuefang Tan et al.
JOURNAL OF VIROLOGY (2011)
CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations
Dennis Christensen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Peptide Nanoparticles as Novel Immunogens: Design and Analysis of a Prototypic Severe Acute Respiratory Syndrome Vaccine
Tais A. P. F. Pimentel et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Coronavirus Diversity, Phylogeny and Interspecies Jumping
Patrick C. Y. Woo et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2009)
SARS vaccines: where are we?
Rachel L. Roper et al.
EXPERT REVIEW OF VACCINES (2009)
Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model
Noriko Tonomura et al.
BLOOD (2008)
Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
Fumihiko Yasui et al.
JOURNAL OF IMMUNOLOGY (2008)
Replicating and non-replicating viral vectors for vaccine development
Marjorie Robert-Guroff
CURRENT OPINION IN BIOTECHNOLOGY (2007)
Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple
Fernando P. Polack
PEDIATRIC RESEARCH (2007)
Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII- dependent entry into B cells in vitro
Yin Wing Kam et al.
VACCINE (2007)
Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants
Damon Deming et al.
PLOS MEDICINE (2006)
Analysis of human coronavirus 229E spike and nucleoprotein genes demonstrates genetic drift between chronologically distinct strains
D Chibo et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome
W Liu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
M Czub et al.
VACCINE (2005)
Overview of Vaccines and vaccination
G Ada
MOLECULAR BIOTECHNOLOGY (2005)
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
ZY Yang et al.
NATURE (2004)
Avoiding deceptive imprinting of the immune response to HIV-1 infection in vaccine development
S Muller
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2004)
Severe acute respiratory syndrome
MD Christian et al.
CLINICAL INFECTIOUS DISEASES (2004)
Increasing the potency of MHC class II-presented epitopes by linkage to Ii-Key peptide
RE Humphreys et al.
VACCINE (2000)
Share Paper
